Company Website

Contact Information:
Pamela Mersinger
pmersinger@akceatx.com
312-882-9716

Stacey Hanna
shanna@akceatx.com
561-305-5472
 

Virtual Exhibit Hall Home

Akcea Therapeutics, an Ionis company specializes in the treatment of hereditary transthyretin amyloidosis with polyneuropathy. Akcea Therapeutics has a patented antisense gene therapy to treat hATTR patients. Akcea Therapeutics offers a full panel, Neuropathy Select of complimentary genetic testing through our partner Ambry Genetics.

Additional Information:
Hereditary TTR Amyloid 101
Complimentary Neuropathy Genetic testing panel
Akcea Therapeutics